Navigation Links
Regado Biosciences Reports Clinical Results for REG1 Anticoagulation System at European Society of Cardiology Congress 2008
Date:9/2/2008

c journals -- Circulation and the Journal of Thrombosis and Haemostasis.

Regado is currently evaluating REG1 in 26 patients undergoing elective percutaneous coronary intervention (PCI). The multi-center, open-label, randomized Phase IIa study designated REVERSAL-PCI will assess whether REG1 can replace standard heparin therapy during the performance of PCI with stenting.

REG1 is the first specific, direct-acting anticoagulant controllable by its matched reversal agent. Regado is developing REG1 for use in patients suffering from acute coronary syndrome who undergo coronary revascularization procedures. These procedures, which include percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG), put patients at a high risk for therapy-related bleeding complications. REG1 is being developed initially to increase therapeutic flexibility and improve patient outcomes in coronary revascularization procedures. Intellectual property covering this technology derives from work originating in Duke University Medical Center's Division of Surgical Sciences, which was not involved in the subsequent clinical studies. Duke exclusively licensed the technology to Regado and will receive certain payments from Regado under this license.

REG1 is a two-component system, consisting of an aptamer-based anticoagulant and its matched reversal agent. The REG1 anticoagulant component, RB006, is a single-stranded, nucleic acid aptamer. RB006 selectively and potently binds to and inhibits factor IXa, a protein that is critical to blood coagulation. The reversal agent, RB007, is a complementary nucleic acid that binds to and neutralizes RB006. The amount of RB007 administered allows physicians to fine tune the pharmacodynamic effect of RB006, from slight reduction in anticoagulation all the way to complete reversal.

About Regado Biosciences

Regado Biosciences is pioneering a new therapeutic field with the discovery and development of two-c
'/>"/>

SOURCE Regado Biosciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
2. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
3. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
4. Regado Biosciences Announces Publication in Circulation of Clinical Trial Results of REG1 Anticoagulation System
5. ImmuneRegen BioSciences Reports Material Transfer Agreement with VaxGen, Inc.
6. ImmuneRegen BioSciences, Inc. Demonstrates Radilex(TM) Increases Disease-Fighting White Blood Cells
7. Upstream Biosciences Acquires Innovative Platform Technology and Drug Candidates for Tropical Parasitic Diseases
8. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
9. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
10. Ardea Biosciences Lead MEK Inhibitor, RDEA119, to Enter Human Clinical Trials in Advanced Cancer Patients
11. Alacrity Biosciences Announces Positive Results from a Phase 2 Study of Its Dry Eye Treatment ALTY-0501
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ATLANTA , June 30, 2015 Legal-Bay ... the first bellwether trial in the multidistrict litigation (MDL) ... scheduled to begin October 13 th , 2015. There ... Inc. which have been consolidated before a federal judge ... that the first bellwether trial will begin in October ...
(Date:6/29/2015)... June 29, 2015  New guidelines released today ... Association give hope for better outcomes to the ... acute ischemic stroke each year. Stryker,s Trevo ® ... used in the clinical trials that provided data ... guidelines strongly recommend endovascular therapy with stent retrievers ...
(Date:6/29/2015)... -- Allergan plc (NYSE: AGN ) today announced ... financial results on Thursday, August 6, 2015, prior ... Company will host a conference call and webcast ... August 6, 2015 to discuss its financial results. The ... Canada (877) 251-7980, International (706) ...
Breaking Medicine Technology:Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 2Legal-Bay Lawsuit Settlement Funding Reports Zimmer NexGen Knee Bellwether Trial to Begin October 13th, 2015 3New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 2New AHA Guidelines For The Early Management And Treatment Of Stroke Will Change The Standard Of Care For Thousands Of Stroke Patients Each Year 3Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 2Allergan to Host Second Quarter 2015 Earnings Conference Call and Webcast 3
... Dyadic International, Inc. ("Dyadic") (OTC Pink: DYAI), ... development, manufacture and sale of enzyme and protein ... industries, today announced financial results for the quarter ... in this press release should be read in ...
... Southern Home Medical Equipment, Inc. (PINKSHEETS: SHOM), a ... equipment to medical institutions, announced today that Encore ... significant growth from Encore Medical Staffing operations in ... started this franchise in December, 2010," says Dr. ...
Cached Medicine Technology:Dyadic International Reports 2011 First Quarter Financial Results 2Dyadic International Reports 2011 First Quarter Financial Results 3Dyadic International Reports 2011 First Quarter Financial Results 4Dyadic International Reports 2011 First Quarter Financial Results 5Southern Home Medical Equipment Reports Significant Growth from Encore Franchisees 2
(Date:6/30/2015)... ... June 30, 2015 , ... NJ Top Dentist, Dr. Susan Goldfarb, had ... a CPR Course for members of the Bergen County Dental Society. She does ... latest CPR recommendations for Healthcare Providers. Life Support from Hackensack Hospital provided the ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... imaging. The company provides high quality record management services for patient records. Medical ... is normally required by physicians and clinics. , With the increase in ...
(Date:6/30/2015)... ... June 30, 2015 , ... Eldermark Software ... Notify™, for the senior care sector. As an innovator of senior care ... to become more efficient and offer residents better care. , This next-generation interactive ...
(Date:6/30/2015)... ... June 30, 2015 , ... Harbor Village Detox ... addiction care in Florida on June 12th. Holly Vasquez-Cortella was recently quoted as ... a website dedicated to reporting on trending addiction news and treatment innovations. The article ...
(Date:6/30/2015)... ... June 30, 2015 , ... Nuretix Research, creators ... Knockout Zone Miami (KO Zone), a state-of-the-art training facility owned by ... Diego de Vera. The partnership will provide KO Zone clients and athletes with ...
Breaking Medicine News(10 mins):Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 2Health News:NJ Top Dentists Presents, Dr. Susan Goldfarb of Advanced Periodontics & Implant Care! 3Health News:Micro Com Systems Ltd Now Specializes in Medical Imaging 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 2Health News:Eldermark Leap-Frogs other Nurse Call and Communication Systems with Notify 3Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 2Health News:Harbor Village Detox’s Clinical Director Is Quoted as an Addiction Expert by The Fix 3Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 2Health News:Top Sports Nutrition Brand, Liporidex, Announces Partnership With Leading Boxing, CrossFit and MMA Gym, Knockout Zone of Miami 3
... is available in French . Montreal -- ... times more likely to develop respiratory or gastrointestinal infections in the ... a Centre d,Hbergement de Soins de Longue Dure (CHLSD). These are ... Canadian Medical Association Journal today. "There certainly seems to ...
... both breast cancers and leukemias, according to two reports published ... Medicine ( http://www.jem.org ). The single protein is ... in the cell. , A team led by Ute Moll ... HSP90 activity rendered normally protected proteins vulnerable to attack and ...
... mothers have garnered accolades for rescuing skinned knees on ... lullabies. Now they,re gaining merit for their offspring,s physical ... published in the journal Psychological Science , Brandeis ... the University of British Columbia and the University of ...
... , MONDAY, Jan. 23 (HealthDay News) -- ... increased risk for respiratory or gastrointestinal infections if they ... or spring, according to a new study. Canadian ... care facilities in Toronto, Ontario, and Montreal and Riviere-du-Loup, ...
... International Conference on Cell Therapy for Cardiovascular Disease ... a comprehensive program dedicated to the evolving field ... of cardiac and vascular disease, as well as ... year,s conference will focus on preclinical and clinical ...
... You could call it paying it forward. A trip to ... what if the information documented as a result of your ... few provinces away? Terry Klassen and his research team ... Canada (PERC) have done just that and the impact of ...
Cached Medicine News:Health News:Emergency room visits risky for elderly residents from long-term care facilities 2Health News:Nurturing mothers rear physically healthier adults 2Health News:Nurturing mothers rear physically healthier adults 3Health News:Certain Seniors at Risk for Infection After ER Visit: Study 2Health News:Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC 2Health News:Global conference on stem cell therapy for heart disease to be held Jan. 25-27 in NYC 3Health News:Pediatric emergency research team hit the mark 2
... factor I (IGF-I or somatomedin C) is a ... It acts as a potent mitogen of cellular ... cell-surface receptors. In the circulation, IGF-I is bound ... the actions of IGF-I by modulating the interaction ...
... somatomedin C) is a 7.6 kDa peptide produced ... potent mitogen of cellular proliferation, exerting its actions ... circulation, IGF-I is bound to IGF-binding proteins (IGFBPs), ... by modulating the interaction of IGF-I with the ...
The Bard Ellik Bladder Evacuator is designed for ease of maneuverability during the removal of tissue sections during transurethral prostatectomy, TURPs, bladder biopsy, etc....
Image Diagnostics' Aspect100U is specifically designed for ease of use and high quality image outcome during urological procedures. Aspect tables benefit from a trim, lightweight design, ensuring a s...
Medicine Products: